Stichting Aescap Life Sciences 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 5:00 pm Purchase | 2022-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Stichting Aescap Life Sciences | 5,406,159 7.600% | 578,787 (+11.99%) | Filing |
| 2022-02-04 4:58 pm Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Stichting Aescap Life Sciences | 4,827,372 6.800% | 1,623,176 (+50.66%) | Filing |
| 2021-02-09 5:00 pm Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Stichting Aescap Life Sciences | 3,204,196 6.400% | 3,204,196 (New Position) | Filing |